- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-4/A Registration of securities issued in business combination transactions
- 10.8 Research Service Agreement, Dated September 9, 2019, by and Between Starton Therapeutics, Inc. F/k/a Chemiocare USA Inc. and Transdermal Research Pharma Laboratories LLC
- 10.9 Assignment Agreement, Dated September 9, 2019 by and Between Starton Therapeutics, Inc. and Alpha to Omega Pharmaceutical Consultants, Inc
- 10.10 Development and Commercial License Agreement, Dated February 10, 2021, by and Between Starton Therapeutics, Inc. and Haisco Pharmaceutical Group Co., LTD
- 10.14 Executive Employment Agreement Effective As of April 27, 2023 by and Between Starton Therapeutics, Inc. and Pedro Lichtinger Waisman
- 10.15 Executive Employment Agreement Dated September 1, 2022 by and Between Starton Therapeutics, Inc. and James C. Oliver
- 10.16 Consulting Agreement Dated July 1, 2018 by and Between Starton Therapeutics, Inc. (F/k/a Chemiocare) and Atr Consultants LLC
- 23.1 Consent of Marcum LLP for Healthwell Acquisition Corp. I's Financial Statements and Notes
- 23.2 Consent of Marcum LLP for Starton Therapeutics, Inc.'s Financial Statements and Notes
- 99.7 Consent of Eric Baum to Be Named As a Director
- 99.8 Consent to Be Named As a Director
- Download Excel data file
- View Excel data file
Exhibit 23.2
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT
We consent to the inclusion in this Registration Statement of HWEL Holdings Corp. on Amendment No. 1 to Form S-4 (File No. 333-271952) of our report dated July 12, 2023, with respect to our audits of the consolidated financial statements of Starton Therapeutics, Inc. as of March 31, 2023 and 2022 and for the years ended March 31, 2023 and 2022, which contains an explanatory paragraph relating to substantial doubt about the ability of Starton Therapeutics, Inc. to continue as a going concern, which report appears in the Proxy Statement/Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus.
/s/ Marcum llp
Marcum llp
New York, New York
July 12, 2023